Preoperative or Postoperative Therapy of Patients With Stages IB, II, IIIA Non-Small Cell Lung Cancer

Upon determination of eligibility, neo-adjuvant patients will be randomly assigned to one of two treatment arms: * ARM A Paclitaxel + Carboplatin + Radiation Therapy + Surgery * ARM B Paclitaxel + Carboplatin + Surgery After surgery neo-adjuvant patients with a complete resection will either receive Paclitaxel + Carboplatin or no therapy, depending on their stage of disease at time of enrollment. Patients with incomplete resection Paclitaxel + Carboplatin + Radiation Therapy. Adjuvant patients who enter the study after complete resection will receive Paclitaxel + Carboplatin with or without Radiation Therapy based on initial stage of disease.